Enterprise of Rosatom State Corporation
Back to website

Industry news


NRC Okays U.S. Isotope Plant Construction Application

SHINE Medical Technologies, a Wisconsin-based producer of medical isotope technologies, announced Dec. 3 that the U.S. Nuclear Regulatory Committee (NRC) has accepted the second and final portion of the company's application for a construction permit to build an accelerator plant for medical isotopes including molybdenum-99, which would in turn create a U.S. supply of technetium-99.

For more information visit www.molecularimaging.net


comments powered by Disqus